麻醉及呼吸设备市场:现状分析与预测(2021年～2027年)

麻醉及呼吸设备的市场规模，在预测期间(2021年～2027年)预计以7％的显着年复合成长率扩大。该市场的成长，主要由于COPD、OSA等呼吸疾病增加，麻醉及呼吸设备管理的认识计划剧增，老年人口增加所促进。

本报告提供麻醉及呼吸设备市场相关调查，市场现状，以及各产品类型，各终端用户，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 市场简介

第2章 调查手法或假设

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对麻醉及呼吸设备市场的影响

第6章 麻醉及呼吸设备市场收益，2019年～2027年

第7章 各产品类型的市场洞察

• 麻醉设备
  • 麻醉仪器
  • 麻醉监控器
  • 麻醉资讯管理系统
  • 其他
• 呼吸设备
  • 呼吸设备
  • 呼吸系统用抛弃式
  • 呼吸检测设备
  • 其他

第8章 各终端用户的市场洞察

• 医院
• 诊所
• 居家医疗设施
• 门诊病人手术中心

第9章 各地区的市场洞察

• 北美
• 欧洲
• 亚太地区
• 其他地区

第10章麻醉及呼吸设备市场市场动态

• 市场促进因素
• 市场课题
• 影响分析

第11章麻醉及呼吸设备市场机会

第12章麻醉及呼吸设备市场趋势

第13章 相关法规

第14章 需求面与供给方面的分析

• 需求面分析
• 供给方面分析

第15章 竞争模式

• 竞争情形
  • 企业占有率，各收益

第16章 企业概要

• SunMed
• Smiths Group plc
• ResMed
• Masimo
• Koninklijke Philips N.V.
• Invacare Corporation
• Teleflex Incorporated
• Hamilton Medical
• GE Healthcare
• Fisher & Paykel Healthcare Limited

第17章 免责声明

Anesthesia and Respiratory Devices Market is anticipated display significant CAGR of 7% over the forecast period (2021-2027). The growth of the global anesthesia and respiratory devices market can be mainly attributed due to the rise in respiratory illnesses such as COPD, and OSA coupled with the surge in awareness programs for anesthesia and respiratory devices & management and the increasing geriatric population, thus contributing significantly to the growth of the market. According to the World Health Organization (WHO), every year about 65 million people suffer from COPD, 334 million people suffer from asthma and over 10 million people develop tuberculosis (TB) globally. Furthermore, the rising number of tobacco smokers will upsurge anesthesia and respiratory devices market size over the forecast timeframe. Smoking causes about 90% of all lung cancer deaths and thus smokers are more likely to die from COPD than non-smokers.

Some of the major players operating in the market include SunMed, Smiths Group plc, ResMed, Masimo, Koninklijke Philips N.V., Invacare Corporation, Teleflex Incorporated, Hamilton Medical, GE Healthcare, Fisher & Paykel Healthcare Limited.

The ongoing COVID-19 pandemic across the world have had a tremendous impact on different spectra of society, the market for anesthesia and respiratory devices is no less impacted by this. In the early phase of the pandemic, due to the increasing cases of COVID-19, all hospitals, globally, had canceled their scheduled and elective surgeries. Acute surgical emergencies were still inevitable and were being addressed in a timely and sensible manner. According to the report published by the British Journal of Surgery, in May 2020, an estimated 585,000 elective surgeries were postponed in the 12-week lockdown in India alone, and 28.4 million elective surgeries worldwide are expected to be canceled or postponed. Thus, the halt of surgical procedures is the major factor that is likely to hamper the usage of anesthesia and respiratory devices.

Insights Presented in the Report

"Amongst Product Type, Respiratory Devices segment dominated the market in 2020"

Based on product type, the market is bifurcated into anesthesia devices and respiratory devices. Amongst them, anesthesia devices is further categorized into anesthesia machines, monitors, and anesthetic information management systems. In addition, respiratory devices is further bifurcated into respiratory equipment, respiratory disposables, and respiratory measurement devices. Technological advancements in respiratory devices further offer segment growth opportunities. Additionally, the rising geriatric population that is prone to various respiratory conditions, increasing healthcare expenditure, and emerging market economies will offer growth potential for respiratory devices in the forthcoming period.

"Amongst End User, Diagnostic Centers category to witness fastest growth rate"

Based on end user, the market is bifurcated into hospitals, clinics, homecare settings, ambulatory surgical centers, and others. Among them, the hospital segment held the largest market share in 2020 and is further projected to maintain its leading position in the market during the forecast period. This is mainly due to the rising adoption of anesthesia and respiratory devices in healthcare settings coupled with growing investments by government and private healthcare facilities to update infrastructure and devices. Due to rising chronic diseases, healthcare facilities focus on providing better diagnoses and treatment of these diseases. As per the Pan American Health Organization, 75% of all hospitalized patients require supplemental oxygen treatment. Furthermore, the high demand for therapeutic devices for homecare settings and the launch of homecare devices by key players is also expected to provide lucrative growth opportunities for the market. For instance, In January 2019, Masimo received the FDA approval for MightSat Rx finger pulse oximeter that can be used at home. According to the Agency for Healthcare Research and Quality (AHRQ), in 2014, 17.2 million hospital visits resulted into at least one surgery.

"North America will Dominate the Market During the Forecast Period"

For a better understanding of the demand of Anesthesia and Respiratory Devices Market, the market is analyzed for major regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific); and Rest of World. Currently, North America dominated the market in 2020. In North America, the enlarged availability of anesthesia and respiratory devices in hospitals coupled with an increased incidence of respiratory disorders and lifestyle-related diseases, are driving this market's development in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), about 40 million adults in the U.S., and about 4.7 million middle and early adolescence age individuals smoke at least one tobacco product every day, including e-cigarettes. Thus, the rising geriatric population, chronic diseases, and the number of surgeries with higher adoption and wide accessibility of advanced anesthesia and respiratory devices in the region is expected to drive the North American anesthesia and respiratory devices market.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The Anesthesia and Respiratory Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1.  MARKET INTRODUCTION

• 1.1.    Market Definitions
• 1.2.    Limitation
• 1.3.    Stakeholders
• 1.4.    Currency used in Report

2.  RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Anesthesia and Respiratory Devices Market
• 2.2. Research Methodology of the Anesthesia and Respiratory Devices Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Anesthesia and Respiratory Devices Market Study

3.   MARKET SYNOPSIS

4.    EXECUTIVE SUMMARY

5.    ANESTHESIA AND RESPIRATORY DEVICES MARKET COVID-19 IMPACT

6.    ANESTHESIA AND RESPIRATORY DEVICES MARKET REVENUE, 2019-2027F

7.   MARKET INSIGHTS BY Product Type

• 7.1. Anesthesia Devices
  • 7.1.1. Anesthesia Machines
  • 7.1.2. Anesthesia Monitors
  • 7.1.3. Anesthetic Information Management Systems
  • 7.1.4. Others
• 7.2. Respiratory Devices
  • 7.2.1. Respiratory Equipment
  • 7.2.2. Respiratory Disposables
  • 7.2.3. Respiratory Measurement Devices
  • 7.2.4. Others

8.   MARKET INSIGHTS BY End User

• 8.1. Hospitals
• 8.2.   Clinics
• 8.3.  Homecare Settings
• 8.4.    Ambulatory Surgical Centers

9.   MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1.                      US US
  • 9.1.2.                      Canada Canada
  • 9.1.3.                      Rest of North America Rest of North America
• 9.2.  Europe
  • 9.2.1.                      Germany Germany
  • 9.2.2.                      Germany UK
  • 9.2.3.                      Germany France
  • 9.2.4.                      Germany Italy
  • 9.2.5.                      Germany Spain
  • 9.2.6.                      Germany Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1.  China
  • 9.3.2.  Japan
  • 9.3.3.   India
  • 9.3.4. Australia
  • 9.3.5.  Rest of Asia-Pacific
• 11.4.               Rest of World 9.4.  Rest of World

10 ANESTHESIA AND RESPIRATORY DEVICES MARKET DYNAMICS

• 12.1.               Market Drivers 10.1.  Market Drivers
• 12.2.               Market Challenges 10.2.  Market Challenges
• 12.3.               Impact Analysis 10.3.   Impact Analysis

11 ANESTHESIA AND RESPIRATORY DEVICES MARKET OPPORTUNITIES

12.  ANESTHESIA AND RESPIRATORY DEVICES MARKET TRENDS

13.   LEGAL & REGULATORY FRAMEWORK

14.   DEMAND AND SUPPLY SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis
  • 14.2.1.  Top Product Launches
  • 14.2.2.  Top Business Partnerships
  • 14.2.3.    Top Business Expansions
  • 14.2.4.  Top Merger and Acquisitions

15.  COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1.                  Company Shares, By Revenue

16.   COMPANY PROFILED COMPANY PROFILED

• 16.1.  SunMed
• 16.2. Smiths Group plc
• 16.3. ResMed
• 16.4.  Masimo
• 16.5. Koninklijke Philips N.V.
• 16.6. Invacare Corporation
• 16.7. Teleflex Incorporated
• 16.8. Hamilton Medical
• 16.9. GE Healthcare
• 16.10. Fisher & Paykel Healthcare Limited

17.   DISCLAIMER